There are very few publications regarding this molecule to date, but several studies have suggested HAR1A as a tumor suppressor in oral cancer [13], hepatocellular carcinoma (HCC) [14], and diffuse glioma [15]. Here, HAR1A is linked to hepatocellular carcinoma.